Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4464 per EA under NDC 00093874101. Its NADAC has been published 566 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093874101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074377On Market Since
6/5/1995
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 566 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4464 per EA |
|---|---|
| All-time high | $1.5484 (Mar 13, 2019) |
| All-time low | $0.4101 (Nov 19, 2025) |
| 52-week high | $0.4943 |
| 52-week low | $0.4101 |
| Median price | $1.0959 |
| Average price | $1.0083 |
| Largest weekly change | +88.6% (Nov 19, 2014) |
| Weeks tracked | 566 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.4464 per EA (NDC 00093874101), effective Jun 24, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 566 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.4101 (Nov 19, 2025) to a high of $1.5484 (Mar 13, 2019), with a median of $1.0959 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 00093874101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification